Ondansetron

Digestive supportAnti-nauseaGI health

Ondansetron

RxPrescription onlyTaken by mouth · As needed · 4–8 mg · Digestive support · Anti-nausea · GI health

Starting at $49/mo

Oral ondansetron, an anti-nausea medication used off-label to support digestive comfort during weight-loss treatments. Ondansetron blocks nausea signals in the gut and brain, making early weeks of weight loss more tolerable.

How many tablets per month?

Monthly
30 tabletsper month

You'll receive 30 tablets per month. $49 billed monthly. Cancel anytime.

Start treatment· $49/mo

Real prices from our pharmacy. Longer plans cost less per month and are billed up front. Pause or cancel anytime.

  • FDA-approved anti-nausea medication
  • Supports digestive comfort during weight loss
  • Oral tablet, as-needed dosing

Every plan includes

  • Personalized, physician-guided plan
  • 30 tablets per month
  • Dispensed by a US-licensed compounding pharmacy
  • Unlimited protocol adjustments and messaging
  • Ongoing support and check-ins
  • Pause or cancel anytime
  • Reviewed by our in-house physicians
  • Physician-guided care
  • Ongoing, expert support
  • 100% online
  • Free, discreet shipping

What is Ondansetron?

(serotonin 5-HT3 antagonist)

Ondansetron is an FDA-approved anti-nausea medication (brand name Zofran). It works by blocking serotonin receptors in the gut and brain that trigger nausea. Off-label use with weight-loss medications like GLP-1 helps users tolerate the common early side effect of nausea.

How it is taken
Taken by mouth
How often
As needed
Dose range
4–8 mg
Form
Digestive support · Anti-nausea · GI health

Support medication

FDA-approved for nausea; off-label support for weight-loss tolerance

Ondansetron is not a weight-loss drug. It is used to manage nausea that commonly occurs in the first 1–2 weeks of GLP-1 therapy or other weight-loss medications. Reducing nausea improves adherence to treatment.

How it works,
week by week.

  1. Day 1

    Your physician prescribes ondansetron if nausea is expected (e.g., starting GLP-1). It can be taken daily or as-needed during the first 1–2 weeks.

  2. Week 1

    Start your weight-loss medication. If nausea occurs, ondansetron provides relief within 30 minutes. Take it as directed.

  3. Weeks 2–3

    Nausea usually diminishes as your body adjusts. You may still use ondansetron as-needed for any residual queasiness.

  4. Week 4+

    Most people find they no longer need ondansetron. The medication is purely supportive; as GLP-1 nausea fades, it is discontinued.

  5. Beyond

    Long-term: ondansetron is not used for ongoing weight loss; it was only for the early adjustment period. Your weight-loss plan continues without it.

What you may notice,
and when.

  • Nausea relief

    works within 30 minutes; effects last 4–8 hours

  • Early support only

    used for first 1–2 weeks, then usually stopped

  • Stays on track

    by reducing nausea, it helps you continue your weight-loss plan

  • No weight-loss effect

    ondansetron is purely supportive, not a weight-loss drug

Individual results vary. Benefits reflect what Zepym Health members commonly report to their physician at check-ins; they are not the results of a clinical trial.

Safety first:
what to know before you start.

Important safety information and common side effects

Ondansetron is generally well-tolerated. Common mild side effects are headache, constipation, and fatigue. Rare serious effects include QT prolongation (heart rhythm changes) in very high doses, though this is uncommon at standard weight-loss-support doses. Do not use if you have a history of QT prolongation or certain heart arrhythmias. Tell your physician about all medications and heart conditions. Stop and seek care for severe headache, fainting, or irregular heartbeat.

The research behind
ondansetron.

Ondansetron is an antinausea drug, used off label as an add-on for nausea from GLP-1 medicines. No randomized trial of it for that purpose was found.

  • Add-on trialsno trial found

    No randomized trial of ondansetron for nausea caused by semaglutide or tirzepatide was found. Its use rests on how the drug works: it blocks serotonin signals that drive nausea.

    PubMed search, no trial found
  • Size of the problem16.6% stopped

    In SELECT, 16.6% of people on semaglutide stopped the trial drug for adverse events, against 8.2% on placebo. This is the scale of the tolerability problem an add-on would have to address.

    SELECT, NEJM 2023
  • Heart rhythmQT warning

    The label says ECG changes, including QT prolongation, have been seen; it advises avoiding use in congenital long QT syndrome and ECG monitoring with electrolyte abnormalities such as low potassium or magnesium.

    Ondansetron tablets prescribing information, DailyMed

What the studies found

  • Prevents chemotherapy-related nausea and vomiting; in a Cochrane review of children, 5-HT3 antagonists appeared better than older drugs (Cochrane CD007786).
  • Registered adult cancer trials treat it as an essential antiemetic against chemotherapy-induced nausea and vomiting (Ashour et al., Frontiers in Pharmacology 2023, systematic review of ClinicalTrials.gov).
  • Its use for GLP-1 nausea has no trial behind it in these sources (PubMed search).

Ondansetron is a prescription antinausea tablet. The trial figures above are for the GLP-1 medicines, not for ondansetron. Any use should be decided with a prescriber.

What this does not say

  • The case for helping GLP-1 nausea is indirect: it rests on how the drug works, not on a trial result.
  • Constipation, headache, diarrhea and malaise are the common adverse reactions on the label.
  • Heart rhythm is the main safety concern; the decision belongs to the prescriber, who will weigh the ECG and electrolytes.

The research
behind it.

Ondansetron is highly effective for chemotherapy-induced and post-operative nausea. GLP-1 users commonly experience nausea in weeks 1–2; ondansetron provides relief.

The medication does not affect weight loss itself; it simply makes the early weeks more tolerable by reducing nausea, allowing people to continue their treatment.

Getting started
takes a few minutes.

  1. 1

    Connect with a physician

    Answer a few questions online and a US-licensed physician reviews your health, history and goals to make sure treatment is right for you. 100% online. No in-person visit required.

  2. 2

    Get your discreet shipment

    If approved, your treatment is compounded by a US-licensed, LegitScript-certified pharmacy, inspected for quality, and shipped discreetly to your door.

  3. 3

    Receive continuous support

    Start with one goal, then keep building over time. Unlimited physician messaging, easy refills and dose adjustments, all from the Zepym Health app.

Start treatment

Frequently asked questions

Contact support
How do I take Ondansetron?

Taken by mouth, as needed. The starting prescription is 1 tablet (4 mg) each time. Your physician sets your own dose and it is printed on your label.

What strengths does Ondansetron come in?

The pharmacy carries 2: 4 mg, 8 mg. Your physician chooses which one you get.

How much arrives in each shipment?

30 tablets at the starting strength, shipped to your door from a licensed US pharmacy.

How does ondansetron help with weight loss?

It doesn't directly help with weight loss. Ondansetron reduces nausea, a common side effect of GLP-1 and other weight-loss medications. By managing nausea, it helps you tolerate the early weeks of treatment and stay on your plan.

Is ondansetron addictive?

No. Ondansetron is not addictive. It is a non-controlled anti-nausea medication. It is safe to use as-needed for nausea relief.

Do I have to take ondansetron?

No. It is optional. If you experience nausea during weight-loss treatment and want relief, your physician can prescribe it. If nausea is mild or absent, you may not need it.

How long do I take ondansetron?

Typically 1–2 weeks, as-needed. Most GLP-1 nausea fades after the first 2–3 weeks as your body adjusts. Once nausea stops, you discontinue ondansetron.

Can I take ondansetron with other medications?

Tell your physician about all medications. Ondansetron has few drug interactions, but some cardiac medications (QT-prolonging drugs) require caution. Your physician will screen for interactions.

Ondansetron educational content reviewed by our physician

Scott Nass, MD Doctor of Medicine, board-certified in Family Medicine

Charles R. Drew University and David Geffen School of Medicine at UCLA. Family Medicine residency at Ventura County Medical Center.

More options
in this area.

  • Injection

    Tirzepatide + B12

    A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with vitamin B12 for energy.

    Starting at $198/mo

  • Injection

    Semaglutide + B12

    A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with vitamin B12 for energy.

    Starting at $99/mo

  • Injection

    Tirzepatide + Glycine

    A weekly dual-action GLP-1/GIP injection for meaningful weight loss and appetite control, paired with glycine for better tolerance.

    Starting at $198/mo

  • Injection

    Semaglutide + Glycine

    A weekly GLP-1 injection that quiets cravings and supports steady, sustainable weight loss, paired with glycine for better tolerance.

    Starting at $99/mo

References

  1. 1.Ondansetron efficacy and safety for chemotherapy-induced and postoperative nausea. Drugs, 2012
  2. 2.GLP-1 receptor agonists and nausea: mechanisms and management strategies. Diabetes Care, 2023

Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. Products are compounded by a licensed pharmacy. The FDA has not reviewed or approved compounded products for any use for safety, efficacy, or quality. Compounded medications are not FDA-approved brand-name products.